Mereo BioPharma Group PLC ADR (MREO) — Free Cash Flow Generation Index
Latest as of September 2023:
1.00x
Mereo BioPharma Group PLC ADR (MREO) has a Free Cash Flow Generation Index of 1.00x as of September 2023. Free cash flow of $2.66 Million represents 1% of operating cash flow ($2.66 Million). Explore MREO capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
1.00x
Free Cash Flow / Operating CF
Free Cash Flow
$2.66 Million
USD
Operating Cash Flow
$2.66 Million
USD
Capital Expenditures
$0.00
USD
Annual Free Cash Flow Generation for Mereo BioPharma Group PLC ADR (None–None)
Year-by-year Free Cash Flow Generation Index for Mereo BioPharma Group PLC ADR. Check MREO cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).